The Giants were planning to introduce Carlos Correa Tuesday but the scheduled news conference was postponed due to a medical concern, reports Ronald Blum of the Associated Press.
Earlier Tuesday, Susan Slusser of the San Francisco Chronicle reported that the postponement was related to the fact that the club was “awaiting test results.”
The Giants and Correa agreed to a 13-year, $350M contract last week, though it was pending a physical and had yet to be officially announced.
At this point, it isn’t known what exactly is causing the holdup, with Blum’s report simply stating that “a medical issue was flagged.”
Beyond that information, anything else is speculation at this point. It isn’t publicly known what the issue is or how serious it is.
It’s also not known if the Giants simply want to conduct further tests or have firm evidence of something that will lead to the deal being called off or restructured.
However, the fact that they are at least delaying the official stamp is a situation that will be worth monitoring.
Over the past eight seasons, Correa has been one of the best shortstops in baseball but one knock against him has been durability.
He has gone to the injured list with various issues in his career, including a torn ligament in his thumb, lower back soreness and a fractured rib.
However, he largely moved past his “injury-prone” label in recent years. He played 58 games in the shortened 60-game season in 2020, followed by 148 contests in 2021.
This most recent season, he went on the IL for a finger contusion and went to the COVID-IL once but still got into 136 games on the year, staying healthy for the entirety of the second half of the season.
Again, it’s worth repeating that we don’t know what the current issue is or the severity of it, but Slusser reports that is not a back problem.
